Evaluation reveals differences in quality for language models on multiple sclerosis, suggesting transparency impacts clinical actionability.
Objective To evaluate and compare the performance of four publicly available large language models—ChatGPT, Gemini, Copilot, and Grok—in answering medical questions related to Multiple Sclerosis, focusing on accuracy, transparency, and clinical actionability. Methods Four publicly available large language models (ChatGPT, Gemini, Grok, and Copilot) were selected based on accessibility and their ability to respond to medical questions. A total of 25 questions—five for each of the five key domains (diagnosis, treatment, prevention, disease control, and disease management)—were developed. The responses generated by the models were evaluated using the DISCERN-AI and NLAT-AI assessment tools. Results The evaluation of four AI chatbots—ChatGPT, Gemini, Copilot, and Grok—on multiple sclerosis (MS) content revealed clear differences in quality and consistency. According to DISCERN-AI criteria, Gemini achieved the highest overall quality, excelling in relevance, transparency, balance, and acknowledgment of uncertainty. Grok ranked second, showing generally balanced results with slightly lower scores than Gemini. ChatGPT exhibited strong yet uneven performance, with particular weaknesses in content addressing vulnerable populations. Copilot demonstrated the weakest overall performance, with consistently lower scores across nearly all criteria. Conclusions Gemini demonstrated the strongest and most consistent performance across all domains, followed by Grok with slightly lower but balanced results. ChatGPT showed strong yet uneven outcomes, with weaknesses in addressing vulnerable populations. Copilot ranked lowest, consistently underperforming across metrics. These findings highlight significant differences among large language models in generating accurate and clinically relevant responses for multiple sclerosis, underscoring the importance of considering each model’s strengths and limitations in healthcare applications.
No takes yet. Share an insight, caveat, or question.
Dastani et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: